NYSE:A - Agilent Technologies Stock Price, Price Target & More

Agilent Technologies trades on the New York Stock Exchange (NYSE) under the ticker symbol "A."

Agilent Technologies announced a quarterly dividend on Wednesday, May 16th. Investors of record on Tuesday, July 3rd will be paid a dividend of $0.149 per share on Wednesday, July 25th. This represents a $0.60 annualized dividend and a yield of 0.95%. The ex-dividend date is Monday, July 2nd. View Agilent Technologies' Dividend History.

Agilent Technologies Inc (NYSE:A) released its quarterly earnings data on Monday, May, 14th. The medical research company reported $0.65 EPS for the quarter, beating the Zacks' consensus estimate of $0.64 by $0.01. The medical research company had revenue of $1.21 billion for the quarter, compared to analyst estimates of $1.21 billion. Agilent Technologies had a return on equity of 18.01% and a net margin of 5.02%. The business's quarterly revenue was up 9.4% on a year-over-year basis. During the same quarter last year, the firm earned $0.58 EPS. View Agilent Technologies' Earnings History.

Agilent Technologies is scheduled to release their next quarterly earnings announcement on Monday, August, 13th 2018. View Earnings Estimates for Agilent Technologies.

Agilent Technologies issued an update on its FY18 earnings guidance on Monday, May, 14th. The company provided earnings per share (EPS) guidance of $2.63-2.67 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $2.70. The company issued revenue guidance of $4.85-4.87 billion, compared to the consensus revenue estimate of $4.92 billion.Agilent Technologies also updated its Q3 guidance to $0.61-0.63 EPS.

11 brokerages have issued 1 year price objectives for Agilent Technologies' stock. Their predictions range from $66.00 to $91.00. On average, they expect Agilent Technologies' stock price to reach $73.9091 in the next year. This suggests a possible upside of 17.3% from the stock's current price. View Analyst Ratings for Agilent Technologies.

11 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Agilent Technologies in the last year. There are currently 1 hold rating and 10 buy ratings for the stock, resulting in a consensus recommendation of "Buy."

Some companies that are related to Agilent Technologies include Illumina (ILMN), Waters (WAT), Mettler-Toledo International (MTD), Bio-Rad Laboratories, Inc. Class A Common Stock (BIO), Bio-Rad Laboratories, Inc. Class B (BIO.B), PerkinElmer (PKI), Integra Lifesciences (IART), Bruker (BRKR), Coherent (COHR), Horiba (HRIBF), Accelerate Diagnostics (AXDX), Pacific Biosciences of California (PACB), Quanterix (QTRX), Fluidigm (FLDM) and Harvard Bioscience (HBIO).

News articles about A stock have trended somewhat positive on Wednesday, Accern Sentiment Analysis reports. The research firm identifies negative and positive news coverage by analyzing more than 20 million news and blog sources. Accern ranks coverage of public companies on a scale of -1 to 1, with scores nearest to one being the most favorable. Agilent Technologies earned a news sentiment score of 0.12 on Accern's scale. They also gave media coverage about the medical research company an impact score of 47.75 out of 100, meaning that recent news coverage is somewhat unlikely to have an effect on the stock's share price in the near future.

Agilent Technologies' stock is owned by many different of institutional and retail investors. Top institutional shareholders include Calamos Advisors LLC (0.29%), Cambiar Investors LLC (0.17%), Bank of Montreal Can (0.07%), Retirement Systems of Alabama (0.05%), Fjarde AP Fonden Fourth Swedish National Pension Fund (0.03%) and CHURCHILL MANAGEMENT Corp (0.02%). Company insiders that own Agilent Technologies stock include Boon Hwee Koh, Didier Hirsch, Dominique Grau, Heidi Fields, Jacob Thaysen, James Cullen, Mark Doak, Michael R Mcmullen, Patrick Kaltenbach, Paul N Clark and Rodney Gonsalves. View Institutional Ownership Trends for Agilent Technologies.

A stock was sold by a variety of institutional investors in the last quarter, including Retirement Systems of Alabama, Bank of Montreal Can, Meag Munich Ergo Kapitalanlagegesellschaft MBH, Clinton Group Inc., State of Alaska Department of Revenue, Campbell & CO Investment Adviser LLC, Fox Run Management L.L.C. and Cambiar Investors LLC. Company insiders that have sold Agilent Technologies company stock in the last year include Boon Hwee Koh, Didier Hirsch, Dominique Grau, Heidi Fields, Jacob Thaysen, Mark Doak, Michael R Mcmullen, Patrick Kaltenbach and Rodney Gonsalves. View Insider Buying and Selling for Agilent Technologies.

A stock was bought by a variety of institutional investors in the last quarter, including Calamos Advisors LLC, Verde Servicos Internacionais S.A., Xact Kapitalforvaltning AB, Fjarde AP Fonden Fourth Swedish National Pension Fund, IFM Investors Pty Ltd, Calamos Wealth Management LLC and DnB Asset Management AS. View Insider Buying and Selling for Agilent Technologies.

Shares of A can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

One share of A stock can currently be purchased for approximately $63.00.

Agilent Technologies has a market capitalization of $20.07 billion and generates $4.47 billion in revenue each year. The medical research company earns $684 million in net income (profit) each year or $2.36 on an earnings per share basis. Agilent Technologies employs 13,500 workers across the globe.

Agilent Technologies' mailing address is 5301 STEVENS CREEK BLVD, SANTA CLARA CA, 95051. The medical research company can be reached via phone at 408-345-8886 or via email at [email protected]